Received Jul 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
swelling/pain at sites; swelling/pain at sites; asked if the vaccine he had in the syringe was Novavax. He nodded "yes."/was told I was given Pfizer.; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 22Feb2025 as dose 1 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient didn't receive COVID-19 vaccine prot. subunit (nvx cov 2373) (NOVAVAX COVID-19 VACCINE). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (Primary Immunization series complete), for covid-19 immunization, reaction(s): "hypersensitivity". The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 22Feb2025, outcome "unknown", described as "asked if the vaccine he had in the syringe was Novavax. He nodded "yes."/was told I was given Pfizer."; VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious), outcome "unknown" and all described as "swelling/pain at sites". Batch/lot number is not provided, and it cannot be obtained.